Simple Plex™ Assays for COVID-19 Research
First, see how Simple Plex assays on the EllaTM platform are used for COVID-19 research. Next, meet Ella and request pricing. Finally, choose the Simple Plex Assay that best meets your needs.
Table of Contents
Real-Time Biological Phenotyping
When researching an acute SARS-CoV-2 infection and the resulting and deadly COVID-19 disease, speed and data quality are key. Ella™ enables cytokine and pro-inflammatory biomarker immunoassays in a multianalyte, automated and standardized format. Get the most reliable immunoassay results in real time with Ella.
- After loading the cartridge, data is available in just 75 minutes, getting you to critical decision points faster
- Factory calibrated cartridges and built-in standard curves minimize inter-lot variability allowing you to get the same measurement anywhere
- 80% reduction in manual steps eliminates operator error and inconsistent results
How Ella Is Helping During the COVID-19 Pandemic
Ella is at the forefront of the fight against COVID-19. The Human Immune Monitoring Center at Mount Sinai is leveraging the high-quality data and real-time results of Ella to understand if an immunologic response during COVID-19 is turning deadly. This insight is helping them determine if novel immuno-modulating therapies have the potential to mediate response to the virus.
Watch this virtual meeting organized by the NIH and FDA, to learn more about the role of cytokines in COVID-19 and how researchers at Mount Sinai established a rapid and quantitative cytokine test on Ella to obtain actionable immune monitoring data during the management of COVID-19 patients.
Researchers at the Ichan School of Medicine at Mount Sinai published in Nature Medicine using The Cytokine Storm Panel on Ella! Read their work, entitled, “An Inflammatory cytokine signature predicts COVID-19 severity and survival”.
Simple Plex Assays for COVID-19 Research: From Your Peers
Profiling Host Responses In COVID-19 Infections: Accelerating Biomarker Research With Ella
"A major advantage of Ella is that it’s very easy to use with virtually no maintenance, and it’s really fast. Simply dilute your sample and you’re ready to go—without the need for manual preparations that can take time and add user variability."
- Dr. Jesús F Bermejo-Martín, Principal Investigator, Institute of Biomedical Research of Salamanca (IBSAL)/Hospital Universitario Río Hortega de Valladolid
Ella Promises Better Clinical Care For Acute Respiratory Failure And Sepsis
"Timely results from Ella have the potential to direct treatment for acute diseases where administration needs to take place in a matter of hours."
- Michael Matthay, M.D., Ph.D., Professor of Medicine, University of California San Francisco
Characterizing T-Cell Immune Responses Against Sars-Cov-2 With Ella
"Ella is a simple and fast immunoassay platform that would be ideal for implementation in higher biosafety facilities, like BSL-3, to study the acute phase of SARS-CoV-2 infection."
- Anthony Tanoto Tan, Ph.D., Senior Research Fellow, Duke-NUS Medical School, Singapore
COVID-19 Research Publications Using Ella
Simple Plex COVID-19 Cytokine Storm Panel
Measure key inflammation markers that are indicative of pathologic inflammatory response with a high-quality multianalyte assay. The 16x4 COVID-19 Cytokine Storm Panel is perfect for batching small numbers of samples and getting results fast.
COVID-19 Cytokine Storm Panel Markers
Simple Plex™ Cytokine Screening Panel
The 32x8 Multiplex Cytokine Screening Panel gives you deep insight into an immunological response across a spectrum of critical markers. Get up to 256 results in just 90 minutes. Learn more about the multiplex cartridge.
Cytokine Screening Panel Markers
In response to the global COVID-19 pandemic, the COVID-19 Cytokine Storm Panel and Multiplex Cytokine Screening Panel are available off the shelf Off-the-shelf cartridges ship within 48 hours in the continental US.
DISCLAIMER: The Ella™ automated immunoassay platform is currently offered For Research Use Only; Not for Use in Diagnostic Procedures.
Bio-Techne's Tools For Coronavirus Research
As a leading company in the life sciences research sector, Bio-Techne develops products and resources to support coronavirus research, including reagents and platforms for SARS-CoV-2 detection, cytokine monitoring, and drug discovery. These tools help the scientific community better understand the mechanisms of infection and develop effective treatments. Learn more about Bio-Techne's portfolio or products for Coronavirus Research.
Simple Plex Applications
Quantify cytokine and pro-inflammatory responses to SARS-CoV-2 infection in 90 minutes using an automated, multianalyte format.
Simple Plex assays enable rapid and reproducible quantification of inflammatory responses such as cytokine release syndrome and sepsis.
Measure key neuroscience biomarkers such as neurofilament light (NF-L) and neurofilament heavy (NF-H) in CSF, plasma, and serum.
Cell Therapy Research and Development
Cell Therapy Research and Development
The Simple Plex HEK 293 HCP 3G assay on the Ella platform offers broad detection coverage of this host cell protein (HCP).
With a four-log range of detection, Simple Plex assays have the sensitivity to pick up even very low picogram-per-milliliter levels of endogenous mouse or rat analytes.
Viral Titer Assays
Viral Titer Assays
Get highly reproducible adeno-associated virus and lentivirus titer data with no manual steps in just 90 minutes.
Other Simple Plex Products